Alfama

ALFAMA is a young pharmaceutical company dedicated to the development of small-molecule drugs for unmet medical needs. ALFAMAs carbon monoxide releasing molecules (CORMs) hold the promise of contributing decisively to the prevention and cure of diseases involving inflammatory, infectious, thrombotic and apoptotic processes. Animal data indicates that various CORMs can be effective against ailments such as acute liver failure, multiple sclerosis, rheumatoid arthritis, transplant rejection, myocardial infarction, stroke, NSAID-induced gastric ulcers, hypertension and infection by antibiotic-resistant strains of bacteria. The core of ALFAMAs science is developed at state-of-the-art research facilities in the metropolitan areas of Lisbon (Portugal), where the company originally started, and Boston (Massachusetts, USA), where the headquarters of the mother company Alfama, Inc. are located. ALFAMAs innovative science and agressive business approch have allowed the company to rec...